Wealthspire Advisors (New York)
MIST icon

Wealthspire Advisors (New York)’s Milestone Pharmaceuticals MIST Stock Holding History

Wealthspire Advisors (New York)’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$188K Buy
140,629
+130,000
+1,223% +$208K ﹤0.01% 1190
2026
Q1 		$12.6K Buy
+10,629
New +$18.6K ﹤0.01% 928
2025
Q4 		– Sell
-1,129
Closed -$2.26K – 2152
2025
Q3 		$2.26K Buy
+1,129
New +$1.99K ﹤0.01% 2577

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Wealthspire Advisors (New York)'s MIST Position: Q2 2026 in Review

Wealthspire Advisors (New York) increased its Milestone Pharmaceuticals (MIST) stake by 1,223% in Q2 2026, buying an estimated $208K and bringing the position to 140,629 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #1190.

Wealthspire Advisors (New York) first reported a position in MIST in Q3 2025 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Wealthspire Advisors (New York) held 140,629 shares of Milestone Pharmaceuticals worth $188K as of Q2 2026.
  • Wealthspire Advisors (New York) bought 130,000 Milestone Pharmaceuticals shares in Q2 2026, an estimated $208K.
  • Milestone Pharmaceuticals made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q2 2026, its #1190 holding.
  • Wealthspire Advisors (New York) first reported a position in Milestone Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2026, filed 11 Aug 2026.